A nurse is caring for a client who is taking rosuvastatin. Which of the following findings should the nurse report to the provider immediately?
Dyspepsia
Elevated creatine kinase
Headache
Mostly cloudy
Decreased HDL cholesterol
The Correct Answer is B
Rationale:
A. Dyspepsia: While dyspepsia can be uncomfortable, it is not a critical finding that requires immediate reporting to the provider. It may be a common side effect of statins but typically does not warrant urgent intervention.
B. Elevated creatine kinase: An elevated creatine kinase level can indicate muscle damage, which is a serious side effect associated with rosuvastatin and other statins. This finding requires immediate reporting to prevent complications such as rhabdomyolysis.
C. Headache: A headache may occur with many medications and does not usually require immediate reporting unless it is severe or persistent.
D. Mostly cloudy: This option does not pertain to any specific clinical finding or symptom and is therefore not relevant to the question.
E. Decreased HDL cholesterol: While low HDL cholesterol can be a concern, it is not as urgent as elevated creatine kinase levels and typically does not require immediate action.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is ["A","D"]
Explanation
Rationale:
A. Terazosin is indicated for the treatment of hypertension as it works by relaxing blood vessels, leading to lower blood pressure.
B. Terazosin is not indicated for heart failure; other medications are typically used to manage this condition.
C. Male pattern baldness is treated with other medications, such as finasteride, rather than terazosin.
D. Terazosin is also indicated for benign prostatic hypertrophy (BPH), as it helps alleviate urinary symptoms associated with this condition by relaxing the smooth muscles in the prostate and bladder neck.
E. Terazosin is not indicated for erectile dysfunction; it is primarily used for hypertension and BPH.
Correct Answer is C
Explanation
Rationale:
A. Sargramostim is a granulocyte-macrophage colony-stimulating factor (GM-CSF) used to stimulate the production of white blood cells but is not specifically indicated for anemia.
B. Filgrastim is a granulocyte colony-stimulating factor (G-CSF) that increases white blood cell counts and is not used for treating anemia.
C. Epoetin is an erythropoiesis-stimulating agent that stimulates red blood cell production, making it the appropriate choice for treating chemotherapy-induced anemia.
D. Romiplostim is a thrombopoietin receptor agonist used to treat thrombocytopenia (low platelet count) and is not indicated for anemia.